Downregulation of B-cell receptor signaling by hematopoietic progenitor kinase 1 (HPK1)-mediated phosphorylation and Ubiquitination of the activated BLNK
- Xiaohong Wang1,
- Ju-Pi Li2,
- Hui-Kai Kuo2,
- Li-Li Chu3,
- Gregory A. Dement1,
- Joung-Liang Lan3,
- Der-Yuan Chen3,
- Chia-Yu Yang2,
- Hongbo Hu1 and
- Tse-Hua Tan1,*
- 1 Baylor College of Medicine, United States;
- 2 National Health Research Institues, Taiwan;
- 3 Taichung Veterans General Hospital, Taiwan
- ↵* Corresponding author; email: ttan{at}bcm.edu
Abstract
Hematopoietic progenitor kinase 1 (HPK1) is a Ste20-like serine/threonine kinase that suppresses immune responses and autoimmunity. B-cell receptor (BCR) signaling activates HPK1 by inducing BLNK/HPK1 interaction. Whether HPK1 can reciprocally regulate BLNK during BCR signaling is unknown. Here we show that HPK1-deficient B cells display hyper-proliferation and hyper-activation of IKK and MAPKs (ERK, p38, and JNK) upon the ligation of BCR. HPK1 attenuates BCR-induced cell activation via inducing BLNK threonine152 phosphorylation, which mediates BLNK/14-3-3 binding. Furthermore, threonine152-phosphorylated BLNK is ubiquitinated at lysine37, 38 and 42 residues, leading to attenuation of MAPK and IKK activation in B cells during BCR signaling. These results reveal a novel negative feedback regulation of BCR signaling by HPK1-mediated phosphorylation, ubiquitination, and subsequent degradation of the activated BLNK.
- Cell signaling
- Immunology
- Lymphocyte
- Protein phosphorylation
- Serine threonine protein kinase
- Ubiquitination
- BLNK
- HPK1
- Received October 5, 2011.
- Accepted February 10, 2012.
- Copyright © 2012, The American Society for Biochemistry and Molecular Biology











